RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5570
Malaria parasiteP. yoelii
Genotype
DisruptedGene model (rodent): PY17X_1111700; Gene model (P.falciparum): PF3D7_0511000; Gene product: translationally-controlled tumor protein homolog (TCTP)
Phenotype Asexual bloodstage; Gametocyte/Gamete; Oocyst; Sporozoite;
Last modified: 21 October 2024, 10:45
  *RMgm-5570
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 38802937
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii 17XNL
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherLin L, Li J
Name Group/DepartmentState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Li
Name InstituteXiamen University
CityXiamen
CountryChina
Name of the mutant parasite
RMgm numberRMgm-5570
Principal name∆pytctp
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageReduced growth/multiplication of asexual blood stage parasites
Gametocyte/Gamete(Severely) reduced gametocyte production
Fertilization and ookineteNot tested
OocystNo oocyst/sporozoite production
SporozoiteNo oocyst/sporozoite production
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of TCTP

Protein (function)
Histamine releasing factor (HRF), originally classified as a tumor protein (translationally controlled tumor protein, TCTP) in mouse erythroleukemia, is found in a wide range of eukaryotes including yeast, plants and animals. The name TCTP was coined as a consequence of cDNA cloning from a human mammary carcinoma and based on the fact that TCTP is regulated at the translational level. HRF plays many different functions and is involved in many physiological processes such as cell proliferation, stress and heat shock responses, and cell death. As an intracellular product, HRF/TCTP has a calcium and tubulin binding properties and has been shown to transiently associate with microtubules during cell cycle. As a calcium-binding protein HRF/TCTP was found to be up-regulated in response to a loss of calcium homeostasis which could be part of a role of HRF in general stress response. As a secreted product, HRF/TCTP has immuno-modulatory roles. In humans, HRF/TCTP induces the release of histamine and modulates cytokine secretion from basophils, eosinophils, and T cells. HRF/TCTP was found to have an inflammatory role in mouse models of asthma and allergy.
HRF is also expressed by a number of eukaryotic parasites, including Plasmodium. Plasmodium HRF/TCTP, which has a high homology to human HRF/TCTP (their amino acid sequences are 33% identical and 54% similar) has been proposed to play an important role during the erythrocytic phase of malarial infection (MacDonald et al., 2001).

Phenotype
Reduced growth/multiplication of asexual blood stage parasites. (Severely) reduced gametocyte production. No oocyst/sporozoite production.

See RMgm-1135, RMgm-1507 and RMgm-2979 for P. berghei mutants lacking expression of TCTP with (slightly) different phenotypes (specifically with regard to sexual/mosquito developement).

Additional information
From the Abstract:
' We showed that promoters with 5′UTR introns had higher activities in driving gene expression than those without 5′UTR introns. The results were confirmed in recombinant parasites expressing an HA‑tagged gene (pytctp) driven by promoter with or without 5′UTR intron'. ....'Finally, the 5′UTR introns were alternatively spliced in different parasite development stages, suggesting an active mechanism employed by the parasites to regulate gene expression in various developmental stages'.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PY17X_1111700
Gene Model P. falciparum ortholog PF3D7_0511000
Gene producttranslationally-controlled tumor protein homolog
Gene product: Alternative nameTCTP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe methods of gene tagging and gene disruption using the CRISPR/Cas9 system were basically as described previously (Zhang C, Xiao B, Jiang Y, Zhao Y, Li Z, Gao H, et al. Efficient editing of malaria parasite genome using the CRISPR/Cas9 system. mBio.
2014;5:e01414‑14.).

To construct the plasmids for tagging PyTCTP with 3 × HA at the N-terminal of the protein and simultaneously generated parasites with or with out the 5′UTR intron, we first amplified a ~ 600-bp segment from the 5’UTR region with or without intron as left homologous arm and a 200–400-bp fragment from N-terminal coding region as right homologous arm. A DNA sequence encoding the 3×HA (YPYDVPDYAGAYPYDVPDYAGAYPYDVP
DYA) was inserted between the left and right arms in the frame and cloned into the pYC5 vector using restriction enzymes Nco I and Sac II.

To construct the plasmid to delete the coding region of the pytctp gene, we used primer pairs K55/K53 and K35/K33 to amplify 5’UTR and 3’UTR regions (~ 500 bp) as left and right homologous arms and cloned them into restriction sites of Kpn I/Nco I and Xho I/Eco RI of the pYC5 vector. Oligonucleotide sequences for sgRNAs designed to target specific sites in the 17XL genome were ligated into the plasmid using enzyme Bsm BI. All oligonucleotides were commercially synthesized by Xiamen Borui Biological Technology Co., Ltd. Transfection, drug selection of transformed parasites and limiting-dilution cloning were performed as described.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6